Xinshang Capital
新尚资本
Xinshang Capital (新尚资本) is a fund that appears in elsewhere's corpus primarily as a co-investor in early-stage deals, with its own institutional profile thinly documented. Per a 2023 暗涌Waves report, it was among the LPs backing ChaoXi Capital's fundraising alongside industrial groups and other marketized fund-of-funds and state-owned investment platforms . Elsewhere's materials show it participating as a follower in the angel round of Yitu Technology (弋途科技) led by Yunqi Capital in late 2023 , and as a co-investor in Qiheshengke Biotechnology's over-100-million-yuan Pre-A round in 2023 alongside Gaorong Capital, Source Code Capital, and Zhongxin Capital . The corpus does not contain a dedicated profile of Xinshang Capital's founding, team, or strategy beyond these deal appearances.
AI-generated — may contain errors, please verify.
Coverage
BlueRun Ventures Leads Rounds, Automotive Communication Chip Firm Lingpao Microelectronics Closes Two Consecutive Rounds Exceeding RMB 100 Million in Total | BlueRun Ventures
a domestic leader in Bluetooth high-precision positioning chips
"Yitu Technology" Raises Tens of Millions in Angel Round Led by Yunqi Capital | Yunxun
Providing middleware solutions for the intelligent transformation of Chinese auto brands
A Fund Moving Against the Tide, Riding the Pulse of the Era丨Entering the Game
Please keep welcoming the "heretical."
Chip/Consumer Electronics/Gene Editing Firms Raise New Funding; Quantum Computers, Micro-Display Chips Achieve Global Leadership | Rongbao · April
Targeting international advanced standards.
Qihe Biotech Closes Over 100 Million Yuan Pre-A Round to Accelerate Development and Application of Novel Gene-Editing Technologies
Accelerate the commercialization of gene-edited breeding.
